Skip to main content
Top
Published in: Drug Safety 5/2003

01-04-2003 | Correspondence

Violation of Homogeneity: A Methodologic Issue in the Use of Data Mining Tools

Authors: David E. Lilienfeld, Savian Nicholas, Daniel J. Macneil, Olga Kurjatkin, Thomas Gelardin

Published in: Drug Safety | Issue 5/2003

Login to get access

Excerpt

The recent publication by Bate et al.[1] suggests that use of the ‘method Bayesian confidence propagation neural network (BCPNN)’ facilitates the identification of signals in the WHO database. As described by Lindquist et al.,[2] the technique is premised on the appropriate use of proportionate reporting rates. Such use makes an implicit assumption regarding the homogeneity of the population to which it is applied. Bate et al.[1] describe the WHO database as one in which 67 countries provide data. We suggest that the assumption of homogeneity is violated by the use of data from so many countries representing diverse medical care delivery systems, regulatory environments, pharmaceutical utilisation, and pharmacovigilance systems. It seems reasonable to conclude that use of BCPNN may result in the identification of potential signals but also create considerable noise. …
Literature
1.
go back to reference Bate A, Lindquist M, Edwards IR, et al. A data mining approach for signal detection and analysis. Drug Saf 2002; 25(6): 393–7PubMedCrossRef Bate A, Lindquist M, Edwards IR, et al. A data mining approach for signal detection and analysis. Drug Saf 2002; 25(6): 393–7PubMedCrossRef
2.
go back to reference Lindquist M, Stahl M, Bate A, et al. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO International Database. Drug Saf 2000; 23(6): 533–42PubMedCrossRef Lindquist M, Stahl M, Bate A, et al. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO International Database. Drug Saf 2000; 23(6): 533–42PubMedCrossRef
3.
go back to reference Cochran WG. Some methods for strengthening the common X2 tests. Biometrics 1954; 10: 417–51CrossRef Cochran WG. Some methods for strengthening the common X2 tests. Biometrics 1954; 10: 417–51CrossRef
4.
go back to reference Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719–48PubMed Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719–48PubMed
5.
go back to reference Fienberg SE. The analysis of cross-classified categorical data. 2nd ed. Cambridge (MA): MIT Press, 1980 Fienberg SE. The analysis of cross-classified categorical data. 2nd ed. Cambridge (MA): MIT Press, 1980
6.
go back to reference Lilienfeld DE. The greening of epidemiology: sanitary physicians and the London Epidemiological Society. Bull Hist Med 1979; 52: 503–28 Lilienfeld DE. The greening of epidemiology: sanitary physicians and the London Epidemiological Society. Bull Hist Med 1979; 52: 503–28
Metadata
Title
Violation of Homogeneity: A Methodologic Issue in the Use of Data Mining Tools
Authors
David E. Lilienfeld
Savian Nicholas
Daniel J. Macneil
Olga Kurjatkin
Thomas Gelardin
Publication date
01-04-2003
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 5/2003
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200326050-00005

Other articles of this Issue 5/2003

Drug Safety 5/2003 Go to the issue

Correspondence

The authors’ reply